Search

Author/Creator Sparrow, M.

3. Dose tailoring of anti‐tumour necrosis factor‐alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response. Issue 2 (February 2015)

Authors:
Ghaly, S.; Costello, S.; Beswick, L.; Pudipeddi, A.; Agarwal, A.; Sechi, A.; Antoniades, S.; Headon, B.; Connor, S.; Lawrance, I. C.; Sparrow, M.; Walsh, A. J.; Andrews, J. M.; AIBDA
Journal:
Internal medicine journal
Issue:
Volume 45:Issue 2(2015)
Page Start:
170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases. Issue 11 (13th October 2017)

Authors:
Mitrev, N.; Vande Casteele, N.; Seow, C. H.; Andrews, J. M.; Connor, S. J.; Moore, G. T.; Barclay, M.; Begun, J.; Bryant, R.; Chan, W.; Corte, C.; Ghaly, S.; Lemberg, D. A.; Kariyawasam, V.; Lewindon, P.; Martin, J.; Mountifield, R.; Radford‐Smith, G.; Slobodian, P.; Sparrow, M.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 11/12(2017)
Page Start:
1037
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗